Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Plasma-derived Therapies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Plasma-derived Therapiesmarket, defines the market attractiveness level of Plasma-derived Therapies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Plasma-derived Therapies industry, describes the types of Plasma-derived Therapies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Plasma-derived Therapies market and the development prospects and opportunities of Plasma-derived Therapies industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Plasma-derived Therapies market in Chapter 13.
By Player:
Takeda
Octaparma
Biotest
CSL Behring LLC
Kedrion
Bayer
Grifols
Bio Products Laboratory (BPL)
Shire
LFB
By Type:
Albumin
Immunoglobulin
Factor VIII
Others
By End-User:
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Plasma-derived Therapies Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Plasma-derived Therapies Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Plasma-derived Therapies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Plasma-derived Therapies Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Plasma-derived Therapies Market Analysis and Outlook to 2022
-
7.1 Global Plasma-derived Therapies Consumption (2017-2022)
-
7.2 United States Plasma-derived Therapies Consumption (2017-2022)
-
7.3 Europe Plasma-derived Therapies Consumption (2017-2022)
-
7.4 China Plasma-derived Therapies Consumption (2017-2022)
-
7.5 Japan Plasma-derived Therapies Consumption (2017-2022)
-
7.6 India Plasma-derived Therapies Consumption (2017-2022)
-
7.7 South Korea Plasma-derived Therapies Consumption (2017-2022)
8 Region and Country-wise Plasma-derived Therapies Market Analysis and Outlook to 2028
-
8.1 Global Plasma-derived Therapies Consumption Forecast (2022-2028)
-
8.2 United States Plasma-derived Therapies Consumption Forecast (2022-2028)
-
8.3 Europe Plasma-derived Therapies Consumption Forecast (2022-2028)
-
8.4 China Plasma-derived Therapies Consumption Forecast (2022-2028)
-
8.5 Japan Plasma-derived Therapies Consumption Forecast (2022-2028)
-
8.6 India Plasma-derived Therapies Consumption Forecast (2022-2028)
-
8.7 South Korea Plasma-derived Therapies Consumption Forecast (2022-2028)
9 Global Plasma-derived Therapies Market Outlook by Types and Applications to 2022
-
9.1 Global Plasma-derived Therapies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Albumin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunoglobulin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Factor VIII Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Plasma-derived Therapies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hemophilia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Primary Immunodeficiencies (PIDs) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Consumption and Growth Rate (2017-2022)
-
9.2.4 Global COVID-19 Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Plasma-derived Therapies Market Outlook by Types and Applications to 2028
-
10.1 Global Plasma-derived Therapies Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Albumin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Plasma-derived Therapies Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Primary Immunodeficiencies (PIDs) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Idiopathic Thrombocytopenic Purpura (ITP) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global COVID-19 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Plasma-derived Therapies Import and Export Analysis (Top 5 Countries)
-
11.1 Global Plasma-derived Therapies Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Plasma-derived Therapies Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Plasma-derived Therapies Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Plasma-derived Therapies Market Competitive Analysis
-
14.1 Takeda
-
14.1.1 Takeda Company Details
-
14.1.2 Takeda Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Plasma-derived Therapies Product and Service
-
14.2 Octaparma
-
14.2.1 Octaparma Company Details
-
14.2.2 Octaparma Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Octaparma Plasma-derived Therapies Product and Service
-
14.3 Biotest
-
14.3.1 Biotest Company Details
-
14.3.2 Biotest Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biotest Plasma-derived Therapies Product and Service
-
14.4 CSL Behring LLC
-
14.4.1 CSL Behring LLC Company Details
-
14.4.2 CSL Behring LLC Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 CSL Behring LLC Plasma-derived Therapies Product and Service
-
14.5 Kedrion
-
14.5.1 Kedrion Company Details
-
14.5.2 Kedrion Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Kedrion Plasma-derived Therapies Product and Service
-
14.6 Bayer
-
14.6.1 Bayer Company Details
-
14.6.2 Bayer Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bayer Plasma-derived Therapies Product and Service
-
14.7 Grifols
-
14.7.1 Grifols Company Details
-
14.7.2 Grifols Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Grifols Plasma-derived Therapies Product and Service
-
14.8 Bio Products Laboratory (BPL)
-
14.8.1 Bio Products Laboratory (BPL) Company Details
-
14.8.2 Bio Products Laboratory (BPL) Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bio Products Laboratory (BPL) Plasma-derived Therapies Product and Service
-
14.9 Shire
-
14.9.1 Shire Company Details
-
14.9.2 Shire Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Shire Plasma-derived Therapies Product and Service
-
14.10 LFB
-
14.10.1 LFB Company Details
-
14.10.2 LFB Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 LFB Plasma-derived Therapies Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Plasma-derived Therapies
-
Figure Plasma-derived Therapies Picture
-
Table Global Plasma-derived Therapies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Plasma-derived Therapies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Plasma-derived Therapies Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Plasma-derived Therapies Consumption by Country (2017-2022)
-
Figure United States Plasma-derived Therapies Consumption and Growth Rate (2017-2022)
-
Table Europe Plasma-derived Therapies Consumption and Growth Rate (2017-2022)
-
Figure China Plasma-derived Therapies Consumption and Growth Rate (2017-2022)
-
Figure Japan Plasma-derived Therapies Consumption and Growth Rate (2017-2022)
-
Figure India Plasma-derived Therapies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Plasma-derived Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Plasma-derived Therapies Consumption Forecast by Country (2022-2028)
-
Figure United States Plasma-derived Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Plasma-derived Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Plasma-derived Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Plasma-derived Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Plasma-derived Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Plasma-derived Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Albumin Consumption and Growth Rate (2017-2022)
-
Figure Global Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure Global Factor VIII Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia Consumption and Growth Rate (2017-2022)
-
Figure Global Primary Immunodeficiencies (PIDs) Consumption and Growth Rate (2017-2022)
-
Figure Global Idiopathic Thrombocytopenic Purpura (ITP) Consumption and Growth Rate (2017-2022)
-
Figure Global COVID-19 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Albumin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Primary Immunodeficiencies (PIDs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Idiopathic Thrombocytopenic Purpura (ITP) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global COVID-19 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Plasma-derived Therapies Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Plasma-derived Therapies Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Plasma-derived Therapies Product and Service
-
Table Octaparma (Foundation Year, Company Profile and etc.)
-
Table Octaparma Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octaparma Plasma-derived Therapies Product and Service
-
Table Biotest (Foundation Year, Company Profile and etc.)
-
Table Biotest Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotest Plasma-derived Therapies Product and Service
-
Table CSL Behring LLC (Foundation Year, Company Profile and etc.)
-
Table CSL Behring LLC Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring LLC Plasma-derived Therapies Product and Service
-
Table Kedrion (Foundation Year, Company Profile and etc.)
-
Table Kedrion Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion Plasma-derived Therapies Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Plasma-derived Therapies Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Plasma-derived Therapies Product and Service
-
Table Bio Products Laboratory (BPL) (Foundation Year, Company Profile and etc.)
-
Table Bio Products Laboratory (BPL) Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio Products Laboratory (BPL) Plasma-derived Therapies Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Plasma-derived Therapies Product and Service
-
Table LFB (Foundation Year, Company Profile and etc.)
-
Table LFB Plasma-derived Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table LFB Plasma-derived Therapies Product and Service
-
